Loading...
•
Jun 30, 2024
American Well Q2 2024 Earnings Report
Announced results for the second quarter of 2024.
Key Takeaways
Amwell reported Q2 2024 financial results, showing progress in U.S. Military Health System deployment and improved adjusted EBITDA outlook due to cost alignment efforts. The company reiterated its 2024 revenue and visit guidance.
Total Revenue was $62.8 million.
Subscription revenue was $27.5 million.
Amwell Medical Group (AMG) visit revenue was $28.7 million.
Gross margin was 37%.
Revenue by Segment
Forward Guidance
Amwell issued improved guidance by $10 million for 2024 Adjusted EBITDA, forecasting a range of between ($150) million to ($145) million from a previous range of between ($160) million to ($155) million. The company also reiterated its 2024 revenue and visit guidance, which calls for: •Revenue in the range of $259 to $269 million •AMG visits between 1.6 and 1.7 million
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...